328 related articles for article (PubMed ID: 17222314)
1. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
Jess T; Loftus EV; Velayos FS; Winther KV; Tremaine WJ; Zinsmeister AR; Scott Harmsen W; Langholz E; Binder V; Munkholm P; Sandborn WJ
Am J Gastroenterol; 2007 Apr; 102(4):829-36. PubMed ID: 17222314
[TBL] [Abstract][Full Text] [Related]
2. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study.
Velayos FS; Loftus EV; Jess T; Harmsen WS; Bida J; Zinsmeister AR; Tremaine WJ; Sandborn WJ
Gastroenterology; 2006 Jun; 130(7):1941-9. PubMed ID: 16762617
[TBL] [Abstract][Full Text] [Related]
3. Risk factors of colorectal cancer in inflammatory bowel disease.
Bansal P; Sonnenberg A
Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
[TBL] [Abstract][Full Text] [Related]
4. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
5. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.
Jess T; Loftus EV; Velayos FS; Harmsen WS; Zinsmeister AR; Smyrk TC; Schleck CD; Tremaine WJ; Melton LJ; Munkholm P; Sandborn WJ
Gastroenterology; 2006 Apr; 130(4):1039-46. PubMed ID: 16618397
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.
Munk EM; Pedersen L; Floyd A; Nørgård B; Rasmussen HH; Sørensen HT
Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355
[TBL] [Abstract][Full Text] [Related]
7. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
Jørgensen KK; Lindström L; Cvancarova M; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
Scand J Gastroenterol; 2012 Sep; 47(8-9):1021-9. PubMed ID: 22577871
[TBL] [Abstract][Full Text] [Related]
8. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
Bernstein CN; Nugent Z; Blanchard JF
Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
[TBL] [Abstract][Full Text] [Related]
9. [Inflammatory bowel disease and colorectal cancer].
Hagymási K; Tulassay Z
Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
[TBL] [Abstract][Full Text] [Related]
10. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
D'Haens GR; Lashner BA; Hanauer SB
Am J Gastroenterol; 1993 Aug; 88(8):1174-8. PubMed ID: 8338083
[TBL] [Abstract][Full Text] [Related]
11. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
[TBL] [Abstract][Full Text] [Related]
12. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
Rubin DT; LoSavio A; Yadron N; Huo D; Hanauer SB
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1346-50. PubMed ID: 17059900
[TBL] [Abstract][Full Text] [Related]
13. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
Bernstein CN; Blanchard JF; Metge C; Yogendran M
Am J Gastroenterol; 2003 Dec; 98(12):2784-8. PubMed ID: 14687833
[TBL] [Abstract][Full Text] [Related]
14. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF
Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
[TBL] [Abstract][Full Text] [Related]
15. Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use.
Siersema PD; Yu S; Sahbaie P; Steyerberg EW; Simpson PW; Kuipers EJ; Triadafilopoulos G
Gastrointest Endosc; 2006 Apr; 63(4):581-6. PubMed ID: 16564855
[TBL] [Abstract][Full Text] [Related]
16. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002.
Kitzmann AS; Pulido JS; Diehl NN; Hodge DO; Burke JP
Ophthalmology; 2008 Jan; 115(1):169-73. PubMed ID: 18166410
[TBL] [Abstract][Full Text] [Related]
17. Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates.
Munkholm P; Loftus EV; Reinacher-Schick A; Kornbluth A; Mittmann U; Esendal B
Digestion; 2006; 73(1):11-9. PubMed ID: 16410688
[TBL] [Abstract][Full Text] [Related]
18. Diabetes and hypertension in isolated sixth nerve palsy: a population-based study.
Patel SV; Holmes JM; Hodge DO; Burke JP
Ophthalmology; 2005 May; 112(5):760-3. PubMed ID: 15878054
[TBL] [Abstract][Full Text] [Related]
19. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
Lindberg J; Stenling R; Palmqvist R; Rutegård J
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]